Moderna CLO has 1,103 RSUs vest into stock
Moderna, Inc. (MRNA) reported that Chief Legal Officer Shannon Thyme Klinger had restricted stock units vest and convert into common stock, followed by share withholding for taxes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) reported that Chief Legal Officer Shannon Thyme Klinger had restricted stock units vest and convert into common stock, followed by share withholding for taxes. On August 27 and 28, 2026, a total of 1,103 RSUs were converted into an equal number of common shares, and 535 shares were withheld to satisfy tax withholding obligations. The filing’s Rule 10b5-1 checkbox was not marked, and no post-transaction share balances were reported.
Insider Trade Summary
1,103 shares exercised/converted
Exercise
6 txns
Insider
Klinger Shannon Thyme
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F4 | 329 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 329 | -- | -- |
| Tax Withholding | Common Stock F2 | 160 | $142.77 | $23K |
| Exercise | Restricted Stock Units F1, F3 | 774 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 774 | -- | -- |
| Tax Withholding | Common Stock F2 | 375 | $149.66 | $56K |
Holdings After Transaction:
Restricted Stock Units — 5,300 contracts (Direct);
Common Stock — 74,129 shares (Direct)
Footnotes (4)
- F1. Restricted stock units convert into common stock on a one-for-one basis.
- F2. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F3. 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F4. 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Key Figures
RSUs converted to common stock: 1,103 shares
Shares withheld for tax obligations: 535 shares
Tax withholding price per share (Aug. 27, 2026): $149.66 per share
+3 more
6 metrics
RSUs converted to common stock
1,103 shares
Total derivative exercises (code M) reported in transactionSummary
Shares withheld for tax obligations
535 shares
Code F transactions for tax withholding related to RSU vesting
Tax withholding price per share (Aug. 27, 2026)
$149.66 per share
375 Moderna common shares delivered or withheld for tax withholding
Tax withholding price per share (Aug. 28, 2026)
$142.77 per share
160 Moderna common shares delivered or withheld for tax withholding
RSUs converted on August 27, 2026
774 units
Restricted stock units converting into common stock on a one-for-one basis
RSUs converted on August 28, 2026
329 units
Restricted stock units converting into common stock on a one-for-one basis
Key Terms
Restricted Stock Units, tax withholding obligations, vested, derivative security
4 terms
Restricted Stock Units financial
"Restricted stock units convert into common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to satisfy tax withholding obligations in connection with the vest"
vested financial
"shares subject to this restricted stock unit award vested on February"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did MRNA report for Shannon Thyme Klinger on August 27–28, 2026?
MRNA reported that 1,103 restricted stock units held by Shannon Thyme Klinger converted into common stock on August 27–28, 2026, and 535 common shares were withheld to cover tax withholding obligations related to these vesting events.
How many Moderna (MRNA) RSUs vested and converted to common stock in this Form 4?
A total of 1,103 restricted stock units converted into 1,103 shares of Moderna common stock. This consisted of 774 RSUs and 329 RSUs converting on August 27 and 28, 2026, respectively, on a one-for-one basis.
Were the reported Moderna (MRNA) insider transactions under a Rule 10b5-1 plan?
No. The Form 4’s Rule 10b5-1 checkbox was not checked, and the footnotes do not state that the transactions were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.
What role does Shannon Thyme Klinger have at Moderna (MRNA) in this Form 4?
Shannon Thyme Klinger is identified as Chief Legal Officer of Moderna, Inc. in this Form 4 and is the reporting person for the RSU conversions and related tax withholding share dispositions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
